For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Verisk Analytics, Inc. (VRSK) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-23): Designation Watch · Gem Score -5 (−100…+100 Quality+Value blend) · Quality 69 · Value -66 · Sentiment 10 (timing only, not weighted)
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Verisk Analytics, Inc.
VRSK NASDAQVerisk Analytics, Inc. is a data analytics and risk assessment company that provides technology-enabled solutions to organizations worldwide. The firm focuses primarily on the insurance industry, offering underwriting tools such as policy forms, rating rules, loss cost estimation, and workflow optimization to support more consistent risk selection and pricing. Verisk Analytics also delivers extensive claims-related services, including property repair estimating platforms and anti-fraud analytics that help insurers detect suspicious activity and improve claims handling efficiency. Beyond core insurance workflows, Verisk Analytics develops predictive analytics and decision-support solutions for areas such as catastrophe and weather risk, global risk analytics, and natural resources intelligence, serving clients in insurance, energy, financial services, government, and broader risk management sectors. Its offerings are typically delivered through subscription-based or long-term arrangements, embedding Verisk’s data and models directly into customers’ operational processes. Founded in 1971 and headquartered in Jersey City, New Jersey, Verisk Analytics today plays a central role in helping institutions quantify, manage, and analyze risk using proprietary datasets, advanced models, and industry-specific expertise.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 6.48
Total Equity: $309.80M
Shares: 140,082,773
Total Debt: $6.28B
Cash: $2.18B
EBITDA: $1.60B
Total Debt: $6.28B
Cash: $2.18B
Revenue: $3.07B
Revenue: $3.07B
Revenue: $3.07B
Total Equity: $309.80M
Tax Rate: 22.5%
Equity: $309.80M
Total Debt: $6.28B
Cash: $2.18B
Current Liabilities: $2.30B
Long-Term Debt: $4.77B
Total Debt: $6.28B
Total Equity: $309.80M
Shares: 140,082,773
Shares: 140,082,773
CapEx: -$244.10M
Shares: 140,082,773
Stock Price: $181.67
Net Income: $908.30M
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 15, 2026 10:49am (8d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $3.0B | $2.5B | $2.7B | $2.9B | $3.1B |
| Cost of Revenue | $1.1B | $824.6M | $876.5M | $901.1M | $925.5M |
| Gross Profit | $1.9B | $1.7B | $1.8B | $2.0B | $2.1B |
| Operating Expenses | $940.3M | $265.9M | $673.2M | $726.7M | $803.3M |
| Operating Income | $1.0B | $1.4B | $1.1B | $1.3B | $1.3B |
| Net Income | $666.2M | $953.9M | $614.6M | $958.2M | $908.3M |
| EBITDA | $1.2B | $1.6B | $1.3B | $1.5B | $1.6B |
| EPS | $4.12 | $6.04 | $4.19 | $6.74 | $6.50 |
| EPS (Diluted) | $4.08 | $6.00 | $4.17 | $6.71 | $6.48 |
Balance Sheet (Annual)
Last updated: Aug 15, 2026 10:33am (8d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $280.3M | $112.5M | $302.7M | $291.2M | $2.2B |
| Total Current Assets | $902.6M | $925.1M | $810.1M | $911.6M | $2.8B |
| Total Assets | $7.8B | $7.0B | $4.4B | $4.3B | $6.2B |
| Current Liabilities | $1.8B | $2.3B | $771.4M | $1.2B | $2.3B |
| Long-Term Debt | $3.3B | $3.7B | $2.9B | $3.1B | $4.8B |
| Total Liabilities | $5.0B | $5.2B | $4.0B | $4.2B | $5.9B |
| Total Equity | $2.8B | $1.8B | $322.2M | $105.0M | $309.8M |
| Retained Earnings | $5.2B | $6.0B | $6.4B | $7.2B | $7.8B |
Cash Flow (Annual)
Last updated: Aug 15, 2026 10:49am (8d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.1B | $1.1B | $1.1B | $1.4B |
| Capital Expenditure | -$268.4M | -$274.7M | -$230.0M | -$223.9M | -$244.1M |
| Free Cash Flow | $887.3M | $784.3M | $830.7M | $920.1M | $1.2B |
| Acquisitions (net) | -$289.8M | -$448.9M | -$83.3M | — | — |
| Net Debt Issued / (Repaid) | $0 | $0 | $495.2M | $590.2M | $698.3M |
| Dividends Paid | -$188.2M | -$195.2M | -$196.8M | -$221.3M | -$251.1M |
| Stock Buybacks | -$475.0M | -$1.7B | -$2.8B | -$1.0B | -$624.0M |
| Net Change in Cash | $61.5M | $12.4M | $10.0M | -$11.5M | $1.9B |
Growth Trends (YoY %)
Last updated: Aug 15, 2026 10:49am (8d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | -16.7% | +7.4% | +7.5% | +6.6% |
| Gross Profit Growth | -13.8% | +7.9% | +9.7% | +8.4% |
| Operating Income Growth | +40.6% | -19.5% | +10.8% | +7.2% |
| Net Income Growth | +43.2% | -35.6% | +55.9% | -5.2% |
| EBITDA Growth | +32.8% | -16.5% | +11.1% | +7.8% |
Dividend History (Last 20)
Last updated: Aug 15, 2026 10:33am (8d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-09-15 | $0.50 | — | — | — |
| 2026-06-15 | $0.50 | — | — | — |
| 2026-03-13 | $0.50 | — | — | — |
| 2025-12-15 | $0.45 | — | — | — |
| 2025-09-15 | $0.45 | — | — | — |
| 2025-06-13 | $0.45 | — | — | — |
| 2025-03-14 | $0.45 | — | — | — |
| 2024-12-13 | $0.39 | — | — | — |
| 2024-09-13 | $0.39 | — | — | — |
| 2024-06-14 | $0.39 | — | — | — |
| 2024-03-14 | $0.39 | — | — | — |
| 2023-12-14 | $0.34 | — | — | — |
| 2023-09-14 | $0.34 | — | — | — |
| 2023-06-14 | $0.34 | — | — | — |
| 2023-03-14 | $0.34 | — | — | — |
| 2022-12-14 | $0.31 | — | — | — |
| 2022-09-14 | $0.31 | — | — | — |
| 2022-06-14 | $0.31 | — | — | — |
| 2022-03-14 | $0.31 | — | — | — |
| 2021-12-14 | $0.29 | — | — | — |
Deep Analysis
Narrative Economics
market-narrative step).
AI Lens 4th lens · how AI reaches this business · 5-yr
2026-08-15Verisk's core asset — loss-cost and contributory claims data pooled from competing carriers under a decades-old antitrust-blessed arrangement, plus ISO policy forms filed across 50 state regulators — is exactly the input insurer AI models need and exactly the thing no amount of compute can synthesize. Cheap models make the data more valuable, not less.
Computer-vision and LLM-based property estimating (photo-to-scope) attacks the Xactimate workflow, and large carriers with their own credible loss experience can use cheap model-building to reduce dependence on ISO advisory loss costs and analytics modules.
Whether the claims/estimating franchise defends on the underlying labor-and-materials price database rather than the interface — observable in Xactimate transaction volumes, renewal pricing, and contractor-side adoption versus CCC/Hover/EagleView-style AI estimators.
Cross-carrier contributory databases that require competitors' voluntary data submission, regulator-filed policy language embedded in millions of contracts, and monthly ZIP-level repair cost data accepted as neutral arbiter by insurers and contractors alike.
AI Lens thesis
Verisk is not sold by the seat and not sold as labor, so AI-driven headcount reduction inside insurers does not mechanically shrink its revenue base — subscriptions track lines of business, premium and claim volume, which persist. AI reaches the company on three channels: it raises the marginal value of proprietary, structured, longitudinal risk data (Verisk owns a genuinely unobtainable pool); it lowers Verisk's own cost of producing content — form drafting, actuarial coding, claims tagging, support — against 70% gross and 44% operating margins where savings can drop through; and it lowers the build cost for adjacent attackers in claims estimating and for large carriers doing in-house modelling. The underwriting/ISO side is the responsibility-shielded, regulator-anchored core and should strengthen; the claims-estimating side is where cheap vision models genuinely change who owns the workflow. Net: structurally favorable, with the dispersion sitting in one segment rather than the whole franchise.
What the market may be underestimating
Upside Agentic underwriting and claims workflows need machine-callable, auditable, regulator-defensible reference data — Verisk can reprice from seat/module subscriptions to per-call data consumption, and higher AI-driven query volume expands rather than cannibalizes the unit.
Downside Contributory data is a cooperative asset: if a few large carriers conclude their own AI makes shared pooling a competitive giveaway and withhold submissions, the pool degrades for everyone and the moat erodes from the supply side, not the customer side.
Outcome range spread 46 · unresolved
Growth Outlook
Analyzed 2026-08-17 16:18The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
Looking at the raw quarterly tape first: revenue has moved $716.8M → $725.3M → $735.6M → $753.0M → $772.6M → $768.3M → $778.8M → $782.6M. That's ~9% over seven quarters, or roughly 5-6% annualized — decelerating, not accelerating. The Q2'25 spike to $253M NI (32.8% margin) and Q2'24's $308M (43%!) look like one-time items rather than run-rate; strip them and net income is bouncing $197-234M on a slow uptrend. Trailing four quarters: revenue ~$3.10B, NI ~$910M, FCF ~$1.19B run-rate. At $23.65B market cap that's ~26x earnings and ~20x FCF, and on EV of ~$27.75B (adding $6.28B debt net of $2.18B cash), ~23x FCF and ~18x EBITDA. Not egregious for a monopoly, but not cheap for 6% top-line.
The synthesis model's $138.96 composite fair value implies ~22x FCF compression to ~$16.5B EV — that requires the market to accept mid-single-digit growth in perpetuity with no multiple support from the moat. I think that's too harsh. Verisk's ISO/AIR datasets are genuinely embedded in insurance workflows; regulators cite their loss cost estimates. A fair range is closer to $150-165 (25-27x FCF), not $135. That still means overvalued at $181.67, just less so — maybe 10-15% rather than 26%. The market-forces narrative that this is a "platform-monopoly, anchored, durable" story is right, and durable moats deserve a premium — but a premium over what growth rate? 6% revenue and -5% recent earnings YoY is the answer that matters, and it doesn't justify 28x.
The contrarian case worth taking seriously: earnings CAGR of 21.6% and FCF CAGR of 19.8% vastly exceed revenue CAGR of 7.1%, meaning the business has been compounding value via margin expansion, buybacks (equity is only $310M against $23.65B cap — massive share retirement), and divestitures (the 2022 financial services sale distorts comps). If operating margins can push from 43.7% toward 47-48% via AI-driven product mix, EPS grows double digits on single-digit revenue. That's the bull thesis and it's not crazy — gross margin is already 69.9% and rising. But the recent -5.2% earnings YoY and Q4'25's 25.3% margin (lowest in the series) suggest the margin expansion story is stalling exactly when the multiple demands it accelerate. Insider activity is net selling on small volumes — neutral to slightly negative, consistent with "no one's rushing to buy at $181." The pb_ratio of 82 is a red herring: it reflects aggressive buybacks eating equity, not distress. Debt/equity of 20x similarly is optical — $6.28B debt against $1.44B OCF is 4.4x, elevated but manageable for this cash profile.
I partially agree with the synthesis "overvalued" call but dissent on magnitude. Fair value $150-160, current $181.67, so ~13-17% overvalued — meaningful but not a scream. The stock has already drawn down 34% from highs per the pre-flight note, so much of the froth is out. What would change my mind: (a) evidence Q1'26's $782.6M is inflecting toward 8%+ growth rather than the 5-6% trend, (b) sustained 30%+ net margins for three consecutive quarters proving the AI/pricing story, or (c) a re-rating catalyst like a major new vertical. What would confirm the bear: another quarter of flat sequential revenue and a print below 27% net margin. The models converge on "overvalued" and I concur directionally, but the market-forces framework correctly notes the narrative is durable — this isn't a story that breaks, it's one that slowly compresses. Sizing matters: this is a "trim, don't short" setup for existing holders and a "wait for $155-160" setup for new buyers, not a table-pound short.
GPT Reading
Verisk looks like exactly what the market thinks it is: a very high-quality, very predictable information-services franchise serving insurance, but one whose valuation still asks for more than the underlying growth really supports. The operating profile is excellent. In 2025, revenue grew to $3.07B from $2.88B, up 6.6%, while operating income reached $1.34B for a 43.7% operating margin and free cash flow hit $1.19B, or nearly 39% of sales. Quarterly revenue has also been impressively steady, rising from $716.8M in 2024-06 to $782.6M in 2026-03, with no real air pockets. Net margins mostly sit around 29-33%, aside from one outsized 43% quarter in mid-2024, which looks non-recurring rather than a new baseline. This is an elite business model with recurring-like economics, strong pricing power, and real embeddedness in customer workflows.
The problem is not quality; it is the mismatch between quality and growth at $181.67. On trailing numbers, the stock trades around 28x earnings, 8.3x sales, and 18.4x EV/EBITDA. Those are not absurd multiples for a mission-critical data asset, but they are full for a company whose recent revenue growth is mid-single-digit and whose quarterly top line appears to be flattening in the high-$760Ms to high-$770Ms range. Q1 2026 revenue of $782.6M was only 3.9% above Q1 2025’s $753.0M, slower than the full-year 2025 growth rate. More importantly, earnings quality is good but not obviously accelerating: 2025 net income of $908.3M was actually below 2024’s $958.2M despite higher revenue, and the latest quarter’s net income of $234.2M was down from $232.3M only marginally up in dollars but down in margin versus the stronger 2025-06 and 2025-09 periods. You can justify a premium multiple for stability and returns, but not a premium that quietly assumes a reacceleration.
The balance sheet also deserves more skepticism than this type of “compounder” often gets. Total debt is $6.28B against $2.18B of cash, leaving roughly $4.1B of net debt, while equity is only $309.8M. The 82x P/B is meaningless in an economic sense because book value is tiny, but it does remind you this is a heavily levered, asset-light model where financial engineering and buybacks can flatter per-share metrics. The better lens is cash generation versus enterprise value. With a $23.65B market cap and roughly $4.1B net debt, enterprise value is about $27.8B. Against $1.19B of free cash flow, that is roughly a 4.3% FCF yield. For a business growing revenue 4-7% and already running at very high margins, that is not cheap; it is the valuation of a scarce, defensive asset with very little room for operational disappointment.
The strongest counterargument is that Verisk may simply deserve this kind of price because there are very few businesses with this combination of resilience, margin structure, and customer stickiness. Gross margin is nearly 70%, operating cash flow is $1.44B, ROIC is a strong 23.6%, and the quarter-to-quarter revenue progression shows none of the cyclicality you would expect from a typical consulting or industrial name. If the insurance ecosystem becomes more dependent on external risk data, catastrophe modeling, and workflow analytics, then 6% growth today may understate the durability of cash flows over the next decade. In that framework, paying 28x earnings for a company that can keep converting around 40% of revenue into free cash flow and steadily repurchase stock is not obviously excessive. I weigh that argument less heavily because the stock already reflects it; I do not see evidence in these numbers that growth is inflecting upward enough to earn multiple expansion from here.
What would change my mind is straightforward. If Verisk can show two or three consecutive quarters of revenue growth reaccelerating into the 7-9% range while sustaining operating margins above 43% and pushing annual free cash flow materially above $1.3B, then today’s multiple would look more defensible and perhaps even modest. Likewise, meaningful deleveraging without sacrificing buyback support would improve the quality of the equity story. On the other hand, if quarterly revenue stays stuck below a $790M run rate, annual revenue growth slips toward 4-5%, or margins drift from the high-20s net / low-40s operating range, the premium should compress. My base case is that this remains an excellent company priced as though excellence alone is enough.
Grok Reading
Verisk’s numbers describe a high-quality franchise that has already matured into a mid-single-digit grower while the multiple still prices something closer to a growth compounder. Annual revenue climbed from $2.88B in 2024 to $3.07B in 2025 (+6.6%), consistent with the 7.1% revenue CAGR and the recent quarterly run-rate of roughly $753–783M; that is steady, subscription-like progression, not acceleration. Operating margin sits at an elite 43.7% and net margin near 30%, with free cash flow of $1.19B on only $244M of capex—an FCF margin around 39% and an FCF yield of roughly 5% at the $23.65B enterprise. The catch is earnings: net income fell from $958M to $908M year-over-year, and the trailing P/E of 28× is being asked to underwrite decelerating top-line growth and slightly negative earnings momentum. EV/EBITDA of 18.4× and EV/revenue of 9.6× embed the same optimism. The balance-sheet optics are distorted rather than broken—$6.28B of debt against $309.8M of equity produces a 20× debt-to-equity and an 82× P/B, but that equity base is the residue of buybacks and an intangibles-heavy model; net debt of about $4.1B is comfortably covered by more than a billion dollars of annual FCF and a 23.6% ROIC. The quantitative composite fair value near $134–139 versus $181.67 is directionally right: the market is paying for durability and incremental AI/pricing leverage that the recent 6–7% growth tape has not yet delivered.
The cleanest contradiction with a pure “overvalued” label is the durability of the cash engine and the structural moat the narrative layer correctly flags. Gross margin near 70% has held across the post-divestiture perimeter, operating cash flow of $1.44B is high-quality, and the insurance data franchise really does sit inside claims and underwriting workflows where switching costs are material. Climate severity, regulatory complexity, and incremental analytics modules give a plausible path to mid-teens FCF growth even if headline revenue stays high-single-digit; the 21.6% earnings CAGR and 19.8% FCF CAGR over the measured window show that operating leverage and capital returns have already done heavy lifting. A smart opponent would also note that 28× for a 40%+ EBITDA-margin infrastructure name with a 1.1% dividend and sub-30% payout is not outrageous if the “platform monopoly” story holds and if any reacceleration into new verticals or AI attach rates appears. Insider activity is noise—routine awards and option-related sales—not a signal. Against that, I weigh the hard print more heavily: revenue confidence is already tagged decelerating, recent earnings are down 5%, and a 35% premium to DCF that assumes perpetual margin or multiple expansion is exactly the setup that compresses when growth stays at 6–7%.
I would flip toward fairly valued or modestly undervalued on two concrete triggers: sustained quarterly revenue growth back above 10% with operating margin holding or expanding past the current 43–44% band, or a clean print that shows AI/new-vertical contribution large enough to lift the forward growth algorithm into double digits while FCF stays above $1.2B. A drop in the multiple toward the low-20s P/E without fundamental deterioration would also reset the risk/reward. Until one of those arrives, the stock at $181.67 looks like a great business priced for a better growth tape than it is delivering.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Verisk runs at the top end of software-like economics for a data/analytics business: gross margin has climbed steadily from 64.7% in 2021 to 69.9% in 2025, operating margin sits at 43.7%, and FCF hit $1.19B in 2025 with OCF/NI of 1.47x. Earnings integrity looks clean - Beneish M at -3.04, Altman Z at 5.48, and accruals of -6.2% of assets all point to reported profit being backed by cash. Revenue growth is modest but consistent post-divestitures (roughly 7% in 2025), and margins are expanding, suggesting real operating leverage on an entrenched subscription base.
Verify before trusting this (5)
- Debt maturity ladder and covenants behind the $4.1B net debt position
- Organic revenue growth rate excluding divestiture effects (2022 revenue reset)
- Customer concentration and subscription renewal rates in insurance analytics segment
- Whether the 2022 OpM spike to 56.3% reflects divestiture gains vs. underlying operations
- Nature of the 10b5-1 plans behind insider option-exercise-and-sell activity
The e2e composite fair value lands at $138.96 and the signal-adjusted FV at $134.31, implying roughly -26% downside from $181.67. Even the most generous method in the stack, the anchored P/E at $179.74, only just touches the current price, while the DCF ($143.84) and EPV floor ($88.40) sit well below. That means the price is being justified almost entirely by paying a premium multiple on today's earnings power - there is no method here that says VRSK is cheap. Earnings quality is high (no haircut needed) and the business is genuinely strong (quality 69, data-monopoly economics, mid-40s operating margin, real FCF, aggressive buyback). Those deserve a premium multiple, and I am willing to lift deserved value toward the anchored-PE read of ~$180 rather than the DCF. But even a quality-generous deserved value of ~$150-160 leaves today's price full to modestly rich, not attractive. The bull case requires perpetual margin expansion and pricing power to already be earned in the multiple; the bear case (cyclicality, in-house alternatives, decelerating growth) is not priced in at all. Net: this is a good business trading at a price that already reflects the good business. No margin of safety.
Verify before trusting this (5)
- Forward organic revenue growth guidance and whether subscription mix is still expanding
- Incremental margin trajectory - is operating margin still stepping up or plateauing
- Client concentration and any signs of large insurers insourcing analytics
- Buyback pace vs FCF and net-debt trajectory
- Any one-time items inflating recent EPS that anchored-PE relies on
The macro tape is mildly supportive - VIX at 14.3, S&P near highs, established risk-on regime - but with beta 0.66 VRSK barely feels it either way; this is a low-torque name that neither rips on risk-on nor gets mauled on risk-off. What actually presses on the stock is the narrative layer, and here the story is working: a platform-monopoly framing with durable characteristics, fresh AI-adoption headlines (XactAI traction, Core Lines Reimagine, subscription strength) that fit neatly into the market's current willingness to pay up for 'AI-enabled data monopolies.' Momentum confirms it - shares up 12% in three months, outpacing commercial services peers. Countervailing it is a persistent analyst/media chorus flagging premium valuation (one headline literally says '142% above fair value'), plus a Delaware ruling forcing VRSK back into a $2.35B deal it tried to walk from - a discrete, name-specific overhang that dents optics on capital discipline. Net: story and tape both lean positive, valuation chatter and the deal ruling temper it. Modest tailwind, not a shove.
Verify before trusting this (4)
- Whether analyst target revisions turn negative after the Delaware ruling and forced deal close
- Any deceleration in XactAI/subscription metrics that would crack the AI-adoption narrative
- Sector rotation out of premium data/analytics compounders if rates back up further
- Integration/leverage commentary once the forced acquisition closes
Verisk is not sold by the seat and not sold as labor, so AI-driven headcount reduction inside insurers does not mechanically shrink its revenue base — subscriptions track lines of business, premium and claim volume, which persist. AI reaches the company on three channels: it raises the marginal value of proprietary, structured, longitudinal risk data (Verisk owns a genuinely unobtainable pool); it lowers Verisk's own cost of producing content — form drafting, actuarial coding, claims tagging, support — against 70% gross and 44% operating margins where savings can drop through; and it lowers the build cost for adjacent attackers in claims estimating and for large carriers doing in-house modelling. The underwriting/ISO side is the responsibility-shielded, regulator-anchored core and should strengthen; the claims-estimating side is where cheap vision models genuinely change who owns the workflow. Net: structurally favorable, with the dispersion sitting in one segment rather than the whole franchise.
None surfaced.
Verify before trusting this (8)
- data-licensing revenue growth
- new AI products priced off the pool
- carrier data-sharing terms renegotiated
- carrier data contribution participation
- new contributory database launches
- antitrust or privacy rule changes
- Xactimate estimate volume trend
- carrier pilots with AI estimators
The world is getting riskier and more data-mediated: cat volatility, litigation-driven severity and multiplying insurance regulation all push insurers toward outsourced risk data rather than in-house rebuilds — structurally favorable for Verisk's moat. But the same world is dampening the growth rate: the hard-market premium surge that lifted carrier spending is fading, macro conditions are tight (10y at 4.63%), and 4.6%-cost debt makes buyback-funded EPS growth more expensive. AI cuts both ways — it lowers the cost for large carriers to build substitutes, while raising the value of proprietary, permissioned historical loss data that models cannot synthesize. Net: the demand for what Verisk sells is secure; the rate at which insurers grow their spend on it is decelerating.